Patents by Inventor Georgios LIOLIOS

Georgios LIOLIOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral solutions comprising fludrocortisone acetate
    Patent number: 11771706
    Abstract: Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: October 3, 2023
    Assignee: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios Liolios, Tsampikos Dimitrios Panagiotopoulos, Konstantinos Pachis
  • ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS
    Publication number: 20230201142
    Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
    Type: Application
    Filed: February 10, 2023
    Publication date: June 29, 2023
    Applicant: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios LIOLIOS, Ioannis PSARRAKIS
  • Oral solutions comprising lisdexamfetamine salts
    Patent number: 11576878
    Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: February 14, 2023
    Assignee: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios Liolios, Ioannis Psarrakis
  • ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS
    Publication number: 20210401781
    Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
    Type: Application
    Filed: April 16, 2020
    Publication date: December 30, 2021
    Applicant: Laboserve Pharmaceutical Company S.A.
    Inventors: Georgios LIOLIOS, Ioannis PSARRAKIS
  • ORAL SOLUTIONS COMPRISING FLUDROCORTISONE ACETATE
    Publication number: 20210260077
    Abstract: Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 26, 2021
    Applicant: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios LIOLIOS, Tsampikos Dimitrios PANAGIOTOPOULOS, Konstantinos PACHIS